The ability of excess saturated fatty acyl-CoA to reduce insulin sensitivity appears to be regulated by the structurally diverse sphingolipid ceramide, according to biomedical research identifying ceramide as the agent responsible for insulin resistance in obese and diabetic non-ruminants with excess sFFA. Here, INS is linked to Insulin resistance.